23 January 2022 in European Radiology
Objectives MRI is the gold standard for soft tissue evaluation in the hip joint. However, CT is superior to MRI in providing clear visualization of bony morphology. The aim of this study is to test the equivalency of MRI-based synthetic CT to conventional CT in quantitatively assessing bony morphology of the hip. Materials and methods A prospective study was performed. Adult patients who underwent MRI and CT of the hips were included. Synthetic CT images were generated from MRI using a deep learning–based image synthesis method. Two readers independently performed clinically relevant measurements for hip morphology, including anterior and posterior acetabular sector angle, acetabular version angle, joint space width, lateral center–edge angle, sharp angle, alpha angle, and femoral head-neck offset on synthetic CT and CT. Inter-method, inter-reader, and intra-reader reliability and agreement were assessed using calculations of intraclass correlation coefficient, standard error of measurement, and smallest detectable change. The equivalency among CT and synthetic CT was evaluated using equivalency statistical testing. Results Fifty-four hips from twenty-seven participants were included. There was no reported hip pathology in the subjects. The observed agreement based on reliability and agreement parameters indicated a strong degree of concordance between CT and synthetic CT. Equivalence statistical testing showed that all synthetic CT measurements are equivalent to the CT measurements at the considered margins. Conclusion In healthy individuals, we demonstrated equivalency of MRI-based synthetic CT to conventional CT for the quantitative evaluation of osseous hip morphology, thus obviating the radiation exposure of a pelvic CT examination. Key Points •MRI-based synthetic CT images can be generated from MRI using a deep learning–based image synthesis method. •MRI-based synthetic CT is equivalent to CT in the quantitative assessment of bony hip morphology in healthy individuals. •MRI-based synthetic CT is promising for use in preoperative diagnosis and surgery planning.
2 March 2018 in Annals of Hematology
1 April 2017 in European Journal of Obstetrics & Gynecology and Reproductive Biology
1 December 2015 in Thrombosis Research
1 January 2025 in Pain Research and Management
Objectives: The aim of this systematic review and meta‐analysis from randomized controlled trials is to assess opioids with or without low‐dose naloxone during the perioperative period at pain intensity and opioids‐related adverse events. Methods: We searched of Medline, Embase, International Clinical Trials Registry Platform, and the Cochrane Library up to May 31, 2023. We included randomized controlled trials (RCTs) of low‐dose naloxone combined with opioids in adults reporting pain intensity or opioid‐related adverse event during the perioperative period. Results: A total of 18 RCTs with 1784 participants were included. We could not reach a consistent conclusion for pain intensity due to high heterogeneity. High certainty evidence showed that low‐dose naloxone combined with opioids reduced the risk of nausea (relative risk (RR): 0.82 and 95% confidence interval (CI): 0.70–0.96), cough (RR: 0.52 and 95% CI: 0.30–0.90) and postoperative nausea and vomiting (RR: 0.58 and 95% CI: 0.40–0.80). Moderate certainty evidence showed that low‐dose naloxone combined with opioids did not reduce vomiting, urinary retention, sedation, dizziness, respiratory depression, headache, drowsiness, shivering, skin itch, hypotension, and sweating. Conclusions: Our findings show that the use of low‐dose naloxone in combination with opioids can lower the risk of somnolence and coughing, postoperative nausea, and vomiting.